Free Trial
NYSE:ELAN

Elanco Animal Health (ELAN) Stock Price, News & Analysis

Elanco Animal Health logo
$13.35 -0.05 (-0.37%)
(As of 11/22/2024 ET)

About Elanco Animal Health Stock (NYSE:ELAN)

Key Stats

Today's Range
$13.16
$13.46
50-Day Range
$12.38
$15.07
52-Week Range
$11.40
$18.80
Volume
3.63 million shs
Average Volume
4.75 million shs
Market Capitalization
$6.60 billion
P/E Ratio
33.38
Dividend Yield
N/A
Price Target
$17.14
Consensus Rating
Hold

Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Elanco Animal Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
83rd Percentile Overall Score

ELAN MarketRank™: 

Elanco Animal Health scored higher than 83% of companies evaluated by MarketBeat, and ranked 193rd out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elanco Animal Health has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 4 buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Elanco Animal Health has only been the subject of 3 research reports in the past 90 days.

  • Read more about Elanco Animal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Elanco Animal Health are expected to grow by 1.10% in the coming year, from $0.91 to $0.92 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elanco Animal Health is 33.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elanco Animal Health is 33.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 105.97.

  • Price to Earnings Growth Ratio

    Elanco Animal Health has a PEG Ratio of 1.39. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Elanco Animal Health has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Elanco Animal Health's valuation and earnings.
  • Percentage of Shares Shorted

    2.81% of the outstanding shares of Elanco Animal Health have been sold short.
  • Short Interest Ratio / Days to Cover

    Elanco Animal Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elanco Animal Health has recently increased by 20.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Elanco Animal Health does not currently pay a dividend.

  • Dividend Growth

    Elanco Animal Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.81% of the outstanding shares of Elanco Animal Health have been sold short.
  • Short Interest Ratio / Days to Cover

    Elanco Animal Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elanco Animal Health has recently increased by 20.49%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Elanco Animal Health has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 28 news articles for Elanco Animal Health this week, compared to 10 articles on an average week.
  • Search Interest

    6 people have searched for ELAN on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Elanco Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Elanco Animal Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $51,975.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.57% of the stock of Elanco Animal Health is held by insiders.

  • Percentage Held by Institutions

    97.48% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elanco Animal Health's insider trading history.
Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

ELAN Stock News Headlines

Buffett's Oil Bet + This 22% Dividend Play
Warren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occidental and Chevron) pay modest dividends of 1.47% and 4%, we've found a way for regular investors to potentially earn a much bigger income stream from the energy boom.
See More Headlines

ELAN Stock Analysis - Frequently Asked Questions

Elanco Animal Health's stock was trading at $14.90 on January 1st, 2024. Since then, ELAN shares have decreased by 10.4% and is now trading at $13.35.
View the best growth stocks for 2024 here
.

Elanco Animal Health Incorporated (NYSE:ELAN) issued its quarterly earnings data on Thursday, November, 7th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.12 by $0.01. The company's revenue for the quarter was down 3.6% on a year-over-year basis.

Elanco Animal Health (ELAN) raised $1.4 billion in an IPO on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

Elanco Animal Health's top institutional investors include Primecap Management Co. CA (10.64%), State Street Corp (2.01%), Geode Capital Management LLC (1.59%) and The Manufacturers Life Insurance Company (1.29%). Insiders that own company stock include R David Hoover, Jeffrey N Simmons, Michael J Harrington, John P Bilbrey and Rajeev A Modi.
View institutional ownership trends
.

Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elanco Animal Health investors own include Salesforce (CRM), Home Depot (HD), Chevron (CVX), Pfizer (PFE), Bank of America (BAC), QUALCOMM (QCOM) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/07/2024
Today
11/22/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/24/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Fax
N/A
Employees
9,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.14
High Stock Price Target
$20.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+28.7%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$-1,231,000,000.00
Pretax Margin
9.25%

Debt

Sales & Book Value

Annual Sales
$4.42 billion
Cash Flow
$2.30 per share
Book Value
$13.19 per share

Miscellaneous

Free Float
491,535,000
Market Cap
$6.58 billion
Optionable
Optionable
Beta
1.41
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:ELAN) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners